178 related articles for article (PubMed ID: 28831081)
1. EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines.
Chakravarty D; Pedraza AM; Cotari J; Liu AH; Punko D; Kokroo A; Huse JT; Altan-Bonnet G; Brennan CW
Sci Rep; 2017 Aug; 7(1):9043. PubMed ID: 28831081
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.
Szerlip NJ; Pedraza A; Chakravarty D; Azim M; McGuire J; Fang Y; Ozawa T; Holland EC; Huse JT; Jhanwar S; Leversha MA; Mikkelsen T; Brennan CW
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3041-6. PubMed ID: 22323597
[TBL] [Abstract][Full Text] [Related]
3. A heat shock protein 90 inhibitor reduces oncoprotein expression and induces cell death in heterogeneous glioblastoma cells with EGFR, PDGFRA, CDK4, and NF1 aberrations.
Ho KT; Chen PF; Chuang JY; Gean PW; Hsueh YS
Life Sci; 2022 Jan; 288():120176. PubMed ID: 34848192
[TBL] [Abstract][Full Text] [Related]
4. Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma.
Burford A; Little SE; Jury A; Popov S; Laxton R; Doey L; Al-Sarraj S; Jürgensmeier JM; Jones C
PLoS One; 2013; 8(8):e71777. PubMed ID: 23990986
[TBL] [Abstract][Full Text] [Related]
5. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
[TBL] [Abstract][Full Text] [Related]
6. EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy.
Skoda J; Neradil J; Zitterbart K; Sterba J; Veselska R
Oncol Rep; 2014 Jan; 31(1):480-7. PubMed ID: 24270553
[TBL] [Abstract][Full Text] [Related]
7. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.
Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN
Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383
[TBL] [Abstract][Full Text] [Related]
8. Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma.
Dewaele B; Floris G; Finalet-Ferreiro J; Fletcher CD; Coindre JM; Guillou L; Hogendoorn PC; Wozniak A; Vanspauwen V; Schöffski P; Marynen P; Vandenberghe P; Sciot R; Debiec-Rychter M
Cancer Res; 2010 Sep; 70(18):7304-14. PubMed ID: 20685895
[TBL] [Abstract][Full Text] [Related]
9. EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma.
Gai QJ; Fu Z; He J; Mao M; Yao XX; Qin Y; Lan X; Zhang L; Miao JY; Wang YX; Zhu J; Yang FC; Lu HM; Yan ZX; Chen FL; Shi Y; Ping YF; Cui YH; Zhang X; Liu X; Yao XH; Lv SQ; Bian XW; Wang Y
Signal Transduct Target Ther; 2022 Feb; 7(1):33. PubMed ID: 35105853
[TBL] [Abstract][Full Text] [Related]
10. In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation.
Riemenschneider MJ; Mueller W; Betensky RA; Mohapatra G; Louis DN
Am J Pathol; 2005 Nov; 167(5):1379-87. PubMed ID: 16251422
[TBL] [Abstract][Full Text] [Related]
11. Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme.
Eller JL; Longo SL; Hicklin DJ; Canute GW
Neurosurgery; 2002 Oct; 51(4):1005-13; discussion 1013-4. PubMed ID: 12234411
[TBL] [Abstract][Full Text] [Related]
12. EGFRvIII tumorigenicity requires PDGFRA co-signaling and reveals therapeutic vulnerabilities in glioblastoma.
Yeo AT; Jun HJ; Appleman VA; Zhang P; Varma H; Sarkaria JN; Charest A
Oncogene; 2021 Apr; 40(15):2682-2696. PubMed ID: 33707748
[TBL] [Abstract][Full Text] [Related]
13. miR-219-5p inhibits receptor tyrosine kinase pathway by targeting EGFR in glioblastoma.
Rao SA; Arimappamagan A; Pandey P; Santosh V; Hegde AS; Chandramouli BA; Somasundaram K
PLoS One; 2013; 8(5):e63164. PubMed ID: 23690991
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma.
Longatto-Filho A; Pinheiro C; Martinho O; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Baltazar F; Reis RM
BMC Cancer; 2009 Jun; 9():212. PubMed ID: 19563658
[TBL] [Abstract][Full Text] [Related]
15. C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells.
Manzano S; Gutierrez-Uzquiza A; Bragado P; Sequera C; Herranz Ó; Rodrigo-Faus M; Jauregui P; Morgner S; Rubio I; Guerrero C; Porras A
Cell Death Dis; 2021 Apr; 12(4):348. PubMed ID: 33824275
[TBL] [Abstract][Full Text] [Related]
16. Heparan Sulfate Synthesized by
Ohkawa Y; Wade A; Lindberg OR; Chen KY; Tran VM; Brown SJ; Kumar A; Kalita M; James CD; Phillips JJ
Mol Cancer Res; 2021 Jan; 19(1):150-161. PubMed ID: 33028660
[TBL] [Abstract][Full Text] [Related]
17. Epithelial growth factor receptor expression influences 5-ALA induced glioblastoma fluorescence.
Fontana AO; Piffaretti D; Marchi F; Burgio F; Faia-Torres AB; Paganetti P; Pinton S; Pieles U; Reinert M
J Neurooncol; 2017 Jul; 133(3):497-507. PubMed ID: 28500562
[TBL] [Abstract][Full Text] [Related]
18. PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.
Ozawa T; Brennan CW; Wang L; Squatrito M; Sasayama T; Nakada M; Huse JT; Pedraza A; Utsuki S; Yasui Y; Tandon A; Fomchenko EI; Oka H; Levine RL; Fujii K; Ladanyi M; Holland EC
Genes Dev; 2010 Oct; 24(19):2205-18. PubMed ID: 20889717
[TBL] [Abstract][Full Text] [Related]
19. Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.
Giannini C; Sarkaria JN; Saito A; Uhm JH; Galanis E; Carlson BL; Schroeder MA; James CD
Neuro Oncol; 2005 Apr; 7(2):164-76. PubMed ID: 15831234
[TBL] [Abstract][Full Text] [Related]
20. ErbB Receptors and Cancer.
Wang Z
Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]